194. Thase ME, Sloan DME. Venlafaxine. En: Textbook of Psychopharmacology, Third Edition. Schatzberg AF, Nemeroff ChB editors. 3º ed. American Psychiatric Press: Washington DC;2004. p. 249-60.
195. Koran LM, Aboujaoude E, Bullock KD. Doubleblind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2005;(3)66:353-9.
196. Pallanti S., Quercioli L., Koran LM. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial. l Clin Psychiatry 2002 Sep;63(9):796-801.
197. Greist JH, Chouniard G, DuBoff E, et al. Double blind parallel comparison of three doses of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52: 289-295.
198.. Greist JH, Jefferson JW. Pharmacotherapy for obsessivecompulsive disorder. Br J Psychiatry Suppl 1998; 35: 64-70
199. Jenike MA. Drug treatment of obsessive-compulsive disorders. En: Jenike MA, Baer L, Minichiello WE. Obsessive-compulsive disorders. Practical Management. 3rd ed. Mosby, St Louis, 1998.
200. Fallon BA, Liebowitz MR, Campeas R, et al. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Arch Gen Psychiatry 1998; 55: 918-924.
201. Mataix-Cols, Rauch SL, Baer L, et al. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry 2002; 159: 263-268.
202. Math SB, Janardhan Reddy. Issues in the pharmacological treatment of obsessive-compulsive disorder. Int J Clin Practice 2007; 61: 1188-1197.
203. Josep Gascón. María José Martin. Pere A Soler Insa. Elena Alea. Alberto Aparicio. Bartolomé Efcacia de la psicocirugía en el trastorno obsesivo compulsivo: Resulatdos preliminares (septiembre 2002) Rev Psiquiatría Fac Med Bama 2002;29(6): 398-409.
204. Oscar Meneses Luna, Francisco Javier Valencia Granados, Manuel Hernández Salazar, Angel Mauricio Soriano Psicocirugía en un paciente con trastorno obsesivo compulsivo resistente Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, ISSN 1134-5934, Vol. 14, Nº 1, 2007, págs. 40-44
205. Baer L, RAuch SL, Ballantine HT JR, et al. Cingulotomy for intractable obsessive-compulsive disorder:prospective long-term follow-up of 18 patients. Arch Gen Psychiatry.1995;52:384-392.
206. Hay P, Sachdev P, Cumming S, et al. Treatment of obsessive compulsive disorder by psychosurgery. Acta Psychiatr Scand.1993;87:197-207.
207. Mindus P, Jenike MA. Neurosurgical treatment of malignant obsessive compulsive disorder. Psychiatr Clin North Am.1992;15:921-938.
208. Jenike MA. Neurosurgical treatment of obsessive-compulsive disorder. Br J Psychiatry 1998; (35) Suppl: 79-90.
209. Gascón J. Protocolo Trastorno obsesivo-compulsivo resistente (TOC). Servicio de neurocirugía y de psiquiatría. Hospital Mutua de Terrassa. Barcelona. personal.redestb.es/jgascon/tocsel.htm
210. Hollander E, Bienstock CA; Koran LM, Refractory obsessive-compulsive disorder: state-of- the-art treatment. J Clin Psychiatry 2002;63(suppl 6):20-9.
211. Greenberg BD, Price LH, Rauch SL, Friehs G, Noren G, Malone D, Carpenter LL, Rezai AR, Rasmussen SA: Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin North Am 2003; 14: 199-212.
212. Baer L, Rauch SL, Ballantine HT Jr, Martuza R, Cosgrove R, Cassem E, Giriunas I, Manzo PA, Dimino C, Jenike MA: Cingulotomy for intractable obsessive-compulsive disorder: prospective long-term follow-up of 18 patients. Arch Gen Psychiatry 1995;52: 384-392
213. Kim CH, Chang JW, Koo MS, Kim JW, Suh HS, Park IH, Lee HS: Anterior cingulotomy for refractory obsessive-compulsive disorder. Acta Psychiatr Scand 2003; 107: 283-290.
214. Mindus P, Jenike MA: Neurosurgical treatment of malignant obsessive compulsive disorder. Psychiatr Clin North Am 1992; 15: 921-938.
215. Rauch SL, Dougherty DD, Eskandar E, Fischman AJ, Jameson M, Cosgrove GR: PET predictor of OCD response to anterior cingulotomy: replication of findings suggests potential clinical utility [ACNP Annual Meeting 2006 Abstracts]. Neuropsychopharmacology 2006; 31(suppl 1): S217.
216. Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B: Electrical stimulation in anterior limbs of internal capsules in patients with obsessive- compulsive disorder. Lancet 1999; 354: 1.526.
217. Anderson D, Ahmed A: Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation: case report. J Neurosurg 2003; 98: 1.104-1.108.
218. Cristina Lóyzaga / Humberto Nicolini Tratamiento farmacológico del trastorno obsesivo compulsivo (TOC) Salud Mental, diciembre, año/vol. 23, número 006. 2000

219. Coric V, Taskiran S Pittenger C, Wasylink S, Mathoalon DH, Valenttine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH: Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry 2005; 58: 424-428.
220. Maletzky B, McFarland B, Burt A: Refractory obsessive compulsive disorder and ECT. Convuls Ther 1994; 10: 34-42.
221. Greenberg BD, Price LH., Rauch SL, Friehs G, Noren G, Malone D, Carpenter LL, Rezai AR, Rasmussen SA: Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin N Am 2003; 14: 199-212.
222. Montgomery SA, Kasper S, Stein DJ, Bang HK, Lemming OM: Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol 2001; 16: 75-86.
223. Stein DJ, Tonnoir B, Andersen EW: Escitalopram in the treatment of OCD [abstract NR717 plus poster]. Presented at the 159th annual meeting of the American Psychiatric Association, Toronto, Ont., Canada, May 20-25, 2006.
224. Goodman WK, Ward H, Kablinger A, Murphy T: Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry 1997; 58(suppl 5): 32-49.
225. Ackerman DL, Greenland S, Bystritsky A: Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 1998; 18: 185-192.
226. Gillman PK: The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13: 100-109.
227. Flament MF, Bisserbe JC: Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. J Clin Psychiatry 1997; 58(suppl 12): 18-22.
228. Tollefson GD, Birkett M, Koran L, Genduso L: Continuation treatment of OCD: double-blind and open-label experience with fluoxetine. J Clin Psychiatry 1994; 55(suppl 10): 69-76.
229. Guest Editors: John H. Greist, MD James W. Jefferson, MD Focus APA Lifelong Learning in PsychiatryTrastorno Obse.sivo-compulsivo (I) American Psychiatric Publishing, Inc., Washington D.C., y Londres, Reino Unido. 2007.